Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 3 6Phase 4 4Phase 1 4Phase EARLY_PHASE1 2Phase 2 2Phase 1/2 1

Status

Withdrawn 1Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 24INDUSTRY 4NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other solid neoplasm 1Lymphoid 1Genitourinary 1Gastrointestinal 1

Conditions

Solid Tumor, Adult 1Opioid-Related Disorders 1Metastatic Castration-resistant Prostate Cancer 1Lymphoma, Follicular 1Carcinoma, Hepatocellular 1

Interventions

pembrolizumab 301Paclitaxel 206Carboplatin 199Gemcitabine 173Cisplatin 138Docetaxel 137Cyclophosphamide 135Nivolumab 129Bevacizumab 118Injections 111fludarabine 95atezolizumab 91Pemetrexed 90Dexamethasone 90Cetuximab 90Fluorouracil 84Irinotecan 77Rituximab 72Capecitabine 72venetoclax 70Azacitidine 70130-nm albumin-bound paclitaxel 67Leucovorin 65Fulvestrant 58Oxaliplatin 57durvalumab 56Trastuzumab 56Lenalidomide 55Ipilimumab 55Midazolam 54

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 1 × INDUSTRY × Blood Specimen Collection × Clear all
NCT06492122 2026-05-26

ProTACT

Full-Life Technologies GmbH

Phase 1 Recruiting
50 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

NCT05251376 2023-01-19

Study of LYN-014 in Individuals With Opioid Use Disorder Who Are Stable on Methadone Therapy

Lyndra Inc.

Phase 1 Withdrawn
Lymphoid

Lymphoma, Follicular, Opioid-Related Disorders

NCT04515043 2021-06-01

EXPLORATORY STUDY Addendum to INVAC1-CT-101 (NCT02301754)

Invectys

Phase 1 Completed
6 enrolled
Other solid neoplasm

Solid Tumor, Adult

NCT01521780 2015-11-02

Characterization of Baseline Biomarker Variability in Participants With Hepatocellular Carcinoma (MK-0000-215)

Merck Sharp & Dohme LLC

Phase 1 Terminated
12 enrolled 7 charts
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡